DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities researchers at William Blair reduced their FY2017 earnings estimates for shares of DENTSPLY SIRONA in a research report issued on Wednesday. William Blair analyst J. Kreger now forecasts that the medical instruments supplier will earn $2.67 per share for the year, down from their prior estimate of $2.83. William Blair also issued estimates for DENTSPLY SIRONA’s FY2018 earnings at $2.90 EPS.

A number of other equities analysts have also weighed in on XRAY. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Wednesday, April 19th. Goldman Sachs Group, Inc. (The) lowered shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. BidaskClub lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. Finally, HC Wainwright initiated coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price for the company. Two analysts have rated the stock with a sell rating, three have issued a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $66.75.

ILLEGAL ACTIVITY WARNING: “DENTSPLY SIRONA Inc. to Post FY2017 Earnings of $2.67 Per Share, William Blair Forecasts (NASDAQ:XRAY)” was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/11/dentsply-sirona-inc-to-post-fy2017-earnings-of-2-67-per-share-william-blair-forecasts-nasdaqxray.html.

DENTSPLY SIRONA (NASDAQ XRAY) traded down 0.52% during mid-day trading on Friday, hitting $55.21. The stock had a trading volume of 216,492 shares. The company has a 50-day moving average price of $63.15 and a 200 day moving average price of $62.30. DENTSPLY SIRONA has a 1-year low of $54.84 and a 1-year high of $65.68. The company’s market cap is $12.67 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.76 earnings per share.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be given a dividend of $0.0875 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.35 annualized dividend and a yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.

A number of large investors have recently modified their holdings of XRAY. Vanguard Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 2.7% in the first quarter. Vanguard Group Inc. now owns 22,165,069 shares of the medical instruments supplier’s stock valued at $1,383,988,000 after buying an additional 584,536 shares during the period. BlackRock Inc. boosted its stake in shares of DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares during the period. State Street Corp boosted its stake in shares of DENTSPLY SIRONA by 0.4% in the first quarter. State Street Corp now owns 9,931,689 shares of the medical instruments supplier’s stock valued at $620,136,000 after buying an additional 36,012 shares during the period. Principal Financial Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 22.3% in the second quarter. Principal Financial Group Inc. now owns 6,474,432 shares of the medical instruments supplier’s stock valued at $419,802,000 after buying an additional 1,181,547 shares during the period. Finally, Veritas Asset Management LLP boosted its stake in shares of DENTSPLY SIRONA by 2.6% in the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after buying an additional 157,616 shares during the period. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.